Healthcare -
Biotechnology - NASDAQ - US
$ 9.25
-0.213 %
$ 646 M
Market Cap
-0.91
P/E
PHAT - CASH & EQUIVALENTS
Cash & Equivalents PHAT - Phathom Pharmaceuticals, Inc.
297 M
LAST VALUE
38.31%
2 YEAR CAGR
4.05%
5 YEAR CAGR
0.00%
10 YEAR CAGR